Amerise Biosciences Reports Q2 FY27 Results with Widened Net Loss
Amerise Biosciences Ltd · Outcome · 30 Oct 2026, 10:11 pm
Amerise Biosciences Reports Q2 FY27 Results with Widened Net Loss Amerise Biosciences reported zero revenue from operations for Q2 ended 30th Sep'26, compared to nil revenue and other income of ₹6.75 lakhs in Q2 ended 30th Sep'25. Net loss for the quarter expanded to ₹5.76 lakhs versus a net loss of ₹4.23 lakhs YoY, driven by employee benefit expenses of ₹0.82 lakhs and other operating expenses of ₹4.94 lakhs. For H1 ended 30th Sep'26, net loss stood at ₹13.91 lakhs against ₹5.04 lakhs YoY. EPS for the quarter was ₹(0.01).
Original exchange filing (PDF)
More announcements from Amerise Biosciences Ltd
- PFA · 30 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd · 30 Oct 2026
- Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Pursuant to Regulation .... · 30 Oct 2026
- PFA · 10 Oct 2026
- PFA · 24 Sept 2026
- PFA · 24 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... · 01 Sept 2026
- PFA · 01 Sept 2026
